Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.

@article{Hviid2013UseOS,
  title={Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.},
  author={A. Hviid and M. Melbye and B. Pasternak},
  journal={The New England journal of medicine},
  year={2013},
  volume={369 25},
  pages={
          2406-15
        }
}
  • A. Hviid, M. Melbye, B. Pasternak
  • Published 2013
  • Medicine
  • The New England journal of medicine
  • BACKGROUND Studies have raised concern about an association between the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and an increased risk of autism spectrum disorders in the offspring. METHODS We conducted a cohort study of all singleton live births in Denmark from 1996 through 2005 (626,875 births), with follow-up through 2009. Using Danish population registries, we linked information on maternal use of SSRIs before and during pregnancy, autism spectrum disorders… CONTINUE READING

    Tables and Topics from this paper.

    Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence
    • 33

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 24 REFERENCES
    Epidemiology of Pervasive Developmental Disorders
    • 1,466
    • PDF